New TB treatment breakthroughs must reach those in-need without delay
SHOBHA SHUKLA – CNS Recently, results of a large-scale phase-3 study of a potentially game-changing TB treatment therapy were announced that give us enormous hope that shorter, all-oral (no injectables), more effective and less toxic treatments will reach those in-need globally without any delay. Earlier, treatment for drug-resistant forms of TB lasted for 20 to 24 months duration or more,…
Read More